Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, Latin America, with growing facilities in Germany, Portugal and the United Kingdom.
In December 2020, the company announced a merger with Aphria, and now operates under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange.
Tilray also owns several breweries and was ranked by the Brewers Association as the 4th largest craft beer company in the US in 2025.Wikipedia
About Tilray Brands Inc
CEOIrwin D.Simon
Employees3.6K
Founded2013
HeadquartersNew York, New York, Canada
SectorPharmaceutical industry
Website-
Analyst ratings
Based on 4 analysts giving stock ratings to TLRY in the past 3 months
Hold
Buy
1
Hold
3
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TLRY in the last 3 months.
Highest
Current $4.54
$8.00 (+76.21%)
Average
$6.13 (+35.02%)
Lowest
$5.00 (+10.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Derek Lessard
TD Cowen
Buy
Maintained
$5.00
+10.1%
07/30/2026
Frederico Gomes
ATB Cormark Capital Markets
Hold
Maintained
$8.00
+76.2%
07/30/2026
Aaron Grey
Alliance Global Partners
Hold
Maintained
$5.00
+10.1%
07/29/2026
Robert Moskow
TD Cowen
Buy
Reiterated
$5.00
+10.1%
07/14/2026
Unknown Analyst
Bernstein
Hold
Maintained
$6.50
+43.2%
06/25/2026
Nadine Sarwat
Bernstein
Hold
Reiterated
-
-
05/12/2026
Kenric Tyghe
Canaccord Genuity
Hold
Maintained
CA$9.50
+109.3%
04/02/2026
Bill Kirk
Roth MKM
Buy
Upgraded
$10.00
+120.3%
04/02/2026
Last report
Jul 28, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
$0.05 / $0.21
-76.19%miss
arrow_downward
Revenue / Est. (USD)
281.71M / 246.30M
+14.38%beat
arrow_upward
Fiscal Q4 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
Quarterly
Annual
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
209.50M
217.51M
206.73M
281.71M
Cost of goods sold
152.03M
160.01M
151.78M
191.19M
Cost of revenue
152.03M
160.01M
151.78M
191.19M
Research and development expenses
41.00K
78.00K
62.00K
180.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.13M
72.94M
69.54M
88.64M
Operating expense
68.10M
77.37M
74.70M
95.01M
Total operating expenses
220.13M
237.38M
226.48M
286.21M
Operating income
-10.63M
-19.88M
-19.75M
-4.49M
Other non operating income
-3.14M
-1.64M
-234.00K
-984.00K
EBT including unusual items
-772.00K
-39.96M
-23.26M
-24.07M
EBT excluding unusual items
-13.54M
-37.22M
-12.48M
-12.10M
Income tax expense
-2.28M
3.55M
1.97M
13.86M
Effective tax rate
295.98%
-8.87%
-8.49%
-57.60%
Other operating expenses
-
-
-
-
Net income
-322.00K
-44.93M
-26.57M
-49.57M
Net profit margin
-0.15%
-20.66%
-12.85%
-17.60%
Earnings per share
-
-0.02
0.02
0.05
Interest and investment income
-
-
-
-
Interest expense
-6.70M
-5.37M
-4.96M
-6.63M
Net interest expenses
-6.70M
-5.37M
-4.96M
-6.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.93M
-3.92M
-3.01M
14.85M
Gain or loss from assets sale
-
-
-
-509.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more